Development and clinical validation of a loop-mediated isothermal amplification method for the rapid detection of Neisseria meningitidis

Adult Adolescent Molecular Sequence Data /dk/atira/pure/subjectarea/asjc/2700/2726 610 Neisseria meningitidis Sensitivity and Specificity Young Adult 03 medical and health sciences 0302 clinical medicine 616 /dk/atira/pure/subjectarea/asjc/2700/2725 name=Microbiology (medical) Humans Child Bacteriological Techniques Base Sequence Infant, Newborn Temperature Infant Reproducibility of Results Middle Aged name=Infectious Diseases name=SDG 3 - Good Health and Well-being 3. Good health Meningococcal Infections Genes, Bacterial Child, Preschool /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being Nucleic Acid Amplification Techniques
DOI: 10.1016/j.diagmicrobio.2010.10.008 Publication Date: 2011-01-19T12:25:34Z
ABSTRACT
Loop-mediated isothermal amplification (LAMP) is an innovative technique that allows the rapid detection of target nucleic acid sequences under isothermal conditions without the need for complex instrumentation. The development, optimization, and clinical validation of a LAMP assay targeting the ctrA gene for the rapid detection of capsular Neisseria meningitidis were described. Highly specific detection of capsular N. meningitidis type strains and clinical isolates was demonstrated, with no cross-reactivity with other Neisseria spp. or with a comprehensive panel of other common human pathogens. The lower limit of detection was 6 ctrA gene copies detectable in 48 min, with positive reactions readily identifiable visually via a simple color change. Higher copy numbers could be detected in as little as 16 min. When applied to a total of 394 clinical specimens, the LAMP assay in comparison to a conventional TaqMan® based real-time polymerase chain reaction system demonstrated a sensitivity of 100% and a specificity of 98.9% with a κ coefficient of 0.942. The LAMP method represents a rapid, sensitive, and highly specific technique for the detection of N. meningitidis and has the potential to be used as a point-of-care molecular test and in resource-poor settings.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (42)